ClinicalTrials.gg
RecruitingNCT07626268CONNECT-AKIUpdated Oct 20, 2026

COordiNated CommuNication, Education, and Care Transitions After Acute Kidney Injury (CONNECT-AKI)

An interventional study of AKI Discharge Summary Template and Chat-Based Educational Messaging Program in Acute Kidney Injury and Acute Kidney Injury (AKI), sponsored by Northwell Health. Recruiting at 2 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-20.

Sponsored by Northwell Health · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Jun 2026; still recruiting 4 months later.
Updated Oct 20, 2026Now RecruitingFirst site in United States+3 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
160
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 370 studies in Acute Kidney Injury with a site in United States — 72 open to participants now, 88 under way, 9 of them phase 3. Acute Kidney Injury · United States.

Planned enrollment
76th of 237
160 · median 67
Started
2026
with 28 others
No phase
106 of 370
25 open now
Primary completion
2026-12
later than 22 of 87 live
Registered
361st of 370
by date

Among the 370 studies in Acute Kidney Injury with a site in United States, this one is the 76th largest by planned enrollment of the 237 interventional ones that give a count, is one of 29 that started in 2026, is one of 106 with no phase, reaches primary completion later than 22 of the 87 other live ones, and was the 361st registered.

Acute Kidney Injury

1,693 studies on the registry are indexed under Acute Kidney Injury; 392 are open to participants now.

Browse Acute Kidney Injury studies →

Open to participants now

72 of the 370 studies in Acute Kidney Injury with a site in United States are open now. Recruiting first, the newest first:

66 more — sign in →

All 72 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 229 Acute Kidney Injury studies recruiting now, 161 (70%) set no upper age limit and 35 (15%) stop at 75 or younger; 22 take children under 18; 25 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 370 studies in Acute Kidney Injury with a site in United States, or all of them as a file.
02

Study summary

The goal of this clinical trial is to learn whether different ways of providing information and follow-up support after acute kidney injury, also called AKI, can improve care transitions for adults being discharged from the hospital. AKI is a sudden decrease in kidney function that can occur during a hospital stay.

The main questions this study aims to answer are:

  • Does an AKI discharge summary template improve communication about AKI after hospital discharge?
  • Does a chat-based educational messaging program improve patient understanding of AKI and support follow-up care after hospital discharge?
  • Researchers will compare usual care, an AKI discharge summary template, a chat-based educational messaging program, and the combination of the discharge summary template plus chat-based messaging.

Researchers will compare four groups:

  • Usual care
  • An AKI discharge summary template
  • A chat-based educational messaging program
  • Both the AKI discharge summary template and the chat-based educational messaging program

Participants will complete questionnaires at the start of the study and about 4 weeks after hospital discharge. Participants will also receive a brief phone call about 3 months after discharge, and the research team will review their medical record for information about follow-up care, lab testing, emergency department visits, and hospital readmissions.

Read the detailed description

Acute kidney injury, also called AKI, is a common complication during hospitalization and is associated with increased risk of poor outcomes after discharge, including incomplete kidney recovery, medication-related safety concerns, emergency department visits, and hospital readmissions. Despite these risks, information about AKI and recommended follow-up care may not always be communicated clearly to patients or outpatient clinicians during the transition from hospital to home.

This pilot randomized clinical trial will evaluate the feasibility and preliminary effects of two care transition strategies for adults hospitalized with AKI. The strategies include an AKI discharge summary template designed to improve communication with outpatient clinicians, and a chat-based educational messaging program designed to provide patients with AKI-related information after discharge.

Participants will be assigned to one of four study groups: usual care, the AKI discharge summary template, the chat-based educational messaging program, or both the discharge summary template and chat-based messaging. The study will assess whether these strategies are feasible to deliver and acceptable to participants, and whether they improve patient knowledge, perceived preparedness, communication about AKI, and completion of recommended follow-up care after hospital discharge.

Participants will complete study questionnaires and allow the research team to review their medical records for information related to kidney function monitoring, follow-up care, emergency department visits, and hospital readmissions. The results of this pilot study will help inform the design of a larger future trial to improve care transitions for patients recovering from AKI.

03

Conditions studied

  • Acute Kidney Injury
  • Acute Kidney Injury (AKI)

Browse trials for

Keywords

  • Acute kidney injury
  • AKI
  • Hospital discharge
  • Care transitions
  • Post-discharge care
  • Patient education
  • Discharge communication
  • Discharge summary
  • Hospital readmission
  • Chat-based education
  • Digital health
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 years or older
  • Hospitalized with Stage 2 or Stage 3 acute kidney injury
  • Kidney function has not returned to baseline at the time of hospital discharge
  • Able to communicate in English
  • Able to provide
  • Willing and able to participate in study procedures independently or with assistance from a patient-designated care partner

Exclusion criteria

Exclusion Criteria:

  • Acute kidney injury requiring ongoing dialysis at the time of hospital discharge
  • End-stage kidney disease
  • Kidney transplant recipient
  • Currently pregnant
  • Documented cognitive impairment that precludes
  • Receiving hospice or comfort-focused end-of-life care
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
160 participants (estimated)

Study arms

  • No intervention
    Usual Care

    Participants assigned to this group will receive usual hospital discharge care. No additional study discharge summary template or chat-based educational messaging program will be provided as part of the intervention.

  • Experimental
    AKI Discharge Summary Template

    Participants in this group will receive usual hospital discharge care plus use of an AKI discharge summary template. The template is designed to support communication of AKI-related information and recommended follow-up care during the transition from hospital to outpatient care.

    Behavioral: AKI Discharge Summary Template

  • Experimental
    Chat-Based Educational Messaging Program

    Participants in this group will receive usual hospital discharge care plus access to a chat-based educational messaging program after hospital discharge. The program provides plain-language AKI education and follow-up support through a secure web-based chat-style interface.

    Behavioral: Chat-Based Educational Messaging Program

  • Experimental
    AKI Discharge Summary Template + Chat-Based Educational Messaging Program

    Participants in this group will receive usual hospital discharge care plus both study interventions: use of the AKI discharge summary template and access to the chat-based educational messaging program after hospital discharge.

    Behavioral: AKI Discharge Summary Template · Behavioral: Chat-Based Educational Messaging Program

Interventions

  • BehavioralAKI Discharge Summary Template

    The AKI discharge summary template provides structured AKI-related information for the hospital discharge summary, including information about the AKI episode and recommended follow-up care. The template is intended to improve communication during the transition from hospital to outpatient care.

  • BehavioralChat-Based Educational Messaging Program

    The chat-based educational messaging program provides AKI-related educational messages after hospital discharge. Messages are delivered through a secure web-based chat-style interface and are designed to support patient understanding of AKI, post-discharge follow-up, and kidney-related care after hospitalization.

06

What researchers measure

Primary outcomes

  1. Feasibility: Eligible patient enrollment

    Percentage of eligible patients enrolled among those approached.

    Time frame: Enrollment period

  2. Feasibility: Participant retention

    Percentage of enrolled participants who complete the follow-up assessment.

    Time frame: Baseline to 3 months after discharge

  3. Feasibility: Successful delivery of assigned intervention components

    Percentage of participants assigned to an intervention arm who receive the assigned intervention component or components as intended, including the AKI discharge summary template and/or chat-based educational messaging program.

    Time frame: Hospital discharge through 4 weeks after discharge

Secondary outcomes

  1. AKI Knowledge Score

    Participant AKI knowledge score measured using a study questionnaire. AKI knowledge is assessed using a 32-item questionnaire. Each item is scored as correct (1) or incorrect (0), yielding a total score ranging from 0 to 32. Higher scores indicate greater knowledge of acute kidney injury.

    Time frame: 4 weeks after hospital discharge

  2. Patient experience during care transitions

    Patient-reported care transition experience measured using a validated transition-of-care instrument, such as the Care Transitions Measure-15. The Care Transitions Measure-15 (CTM-15) is a 15-item questionnaire assessing patient-reported quality of care transitions. Items are rated from 1 (strongly disagree) to 4 (strongly agree). The mean item score is transformed to a scale ranging from 0 to 100, with higher scores indicating better quality of care transitions.

    Time frame: 4 weeks after hospital discharge

  3. Self-management behaviors related to kidney health

    Participant-reported self-management behaviors related to kidney health after hospital discharge, assessed using a study questionnaire. Kidney-related self-management behaviors and confidence are assessed using three study-developed items addressing: 1) fluid-intake monitoring as recommended; 2) avoidance of potentially kidney-harming medications unless approved by a healthcare provider; and 3) confidence recognizing symptoms requiring medical attention. Response options are "Yes," "No," and "I did not receive instructions." For each item, the percentage selecting each response will be calculated among participants who answered that item. Items are reported separately; no total score is calculated.

    Time frame: 4 weeks after hospital discharge

  4. Adherence to outpatient follow-up appointments

    Percentage of participants who complete follow-up with a primary care provider or specialist after hospital discharge, assessed by participant report and/or medical record review.

    Time frame: 4 weeks after hospital discharge, and 3 months after hospital discharge

  5. Patient-reported discussion of AKI with outpatient provider

    Percentage of participants who report discussing AKI or kidney-related follow-up needs with an outpatient provider after hospital discharge.

    Time frame: 4 weeks after hospital discharge

  6. Self-management behaviors related to kidney health

    Participant-reported self-management behaviors related to kidney health after hospital discharge, assessed using a study questionnaire.

    Time frame: 4 weeks after hospital discharge

Other outcomes

  1. Hospital readmission

    Percentage of participants readmitted to the hospital after discharge from the index hospitalization.

    Time frame: Within 4 weeks and within 3 months after hospital discharge

  2. Kidney function trajectory after discharge

    Kidney function status after hospital discharge, categorized as improved, stable, worsened, or requiring dialysis, based on available laboratory and clinical data.

    Time frame: Within 4 weeks and within 3 months after hospital discharge

07

Study locations

2 of 2 sites recruiting
08

References and documents

Publications

  • Wright JA, Wallston KA, Elasy TA, Ikizler TA, Cavanaugh KL. Development and results of a kidney disease knowledge survey given to patients with CKD. Am J Kidney Dis. 2011 Mar;57(3):387-95. doi: 10.1053/j.ajkd.2010.09.018. Epub 2010 Dec 18. PubMed 21168943 ↗
  • Coleman EA, Mahoney E, Parry C. Assessing the quality of preparation for posthospital care from the patient's perspective: the care transitions measure. Med Care. 2005 Mar;43(3):246-55. doi: 10.1097/00005650-200503000-00007. PubMed 15725981 ↗
  • Piette JD, Striplin D, Marinec N, Chen J, Trivedi RB, Aron DC, Fisher L, Aikens JE. A Mobile Health Intervention Supporting Heart Failure Patients and Their Informal Caregivers: A Randomized Comparative Effectiveness Trial. J Med Internet Res. 2015 Jun 10;17(6):e142. doi: 10.2196/jmir.4550. PubMed 26063161 ↗
  • Li WY, Chiu FC, Zeng JK, Li YW, Huang SH, Yeh HC, Cheng BW, Yang FJ. Mobile Health App With Social Media to Support Self-Management for Patients With Chronic Kidney Disease: Prospective Randomized Controlled Study. J Med Internet Res. 2020 Dec 15;22(12):e19452. doi: 10.2196/19452. PubMed 33320101 ↗
  • Hall AK, Cole-Lewis H, Bernhardt JM. Mobile text messaging for health: a systematic review of reviews. Annu Rev Public Health. 2015 Mar 18;36:393-415. doi: 10.1146/annurev-publhealth-031914-122855. PubMed 25785892 ↗
  • Lopez-Vargas PA, Tong A, Howell M, Craig JC. Educational Interventions for Patients With CKD: A Systematic Review. Am J Kidney Dis. 2016 Sep;68(3):353-70. doi: 10.1053/j.ajkd.2016.01.022. Epub 2016 Mar 26. PubMed 27020884 ↗
  • Robelia PM, Kashiwagi DT, Jenkins SM, Newman JS, Sorita A. Information Transfer and the Hospital Discharge Summary: National Primary Care Provider Perspectives of Challenges and Opportunities. J Am Board Fam Med. 2017 Nov-Dec;30(6):758-765. doi: 10.3122/jabfm.2017.06.170194. PubMed 29180550 ↗
  • Howard SJ, Elvey R, Ohrnberger J, Turner AJ, Anselmi L, Martindale AM, Blakeman T. Post-discharge care following acute kidney injury: quality improvement in primary care. BMJ Open Qual. 2020 Dec;9(4):e000891. doi: 10.1136/bmjoq-2019-000891. PubMed 33328317 ↗
  • Chadwick W, Bassett H, Hendrickson S, Slonaker K, Perales S, Pantaleoni J, Srinivas N, Platchek T, Destino L. An Improvement Effort to Optimize Electronically Generated Hospital Discharge Instructions. Hosp Pediatr. 2019 Jul;9(7):523-529. doi: 10.1542/hpeds.2018-0251. PubMed 31243058 ↗
  • Newnham H, Barker A, Ritchie E, Hitchcock K, Gibbs H, Holton S. Discharge communication practices and healthcare provider and patient preferences, satisfaction and comprehension: A systematic review. Int J Qual Health Care. 2017 Oct 1;29(6):752-768. doi: 10.1093/intqhc/mzx121. PubMed 29025093 ↗
  • Nye C, Lake S. Acute kidney injury; improving the communication from secondary to primary care. BMJ Qual Improv Rep. 2017 Jun 23;6(1):u211147.w6661. doi: 10.1136/bmjquality.u211147.w6661. eCollection 2017. PubMed 28674612 ↗
  • Silver SA, Goldstein SL, Harel Z, Harvey A, Rompies EJ, Adhikari NK, Acedillo R, Jain AK, Richardson R, Chan CT, Chertow GM, Bell CM, Wald R. Ambulatory care after acute kidney injury: an opportunity to improve patient outcomes. Can J Kidney Health Dis. 2015 Oct 6;2:36. doi: 10.1186/s40697-015-0071-8. eCollection 2015. PubMed 26445676 ↗
  • Silver SA, Saragosa M, Adhikari NK, Bell CM, Harel Z, Harvey A, Kitchlu A, Neyra JA, Wald R, Jeffs L. What insights do patients and caregivers have on acute kidney injury and posthospitalisation care? A single-centre qualitative study from Toronto, Canada. BMJ Open. 2018 Jun 15;8(6):e021418. doi: 10.1136/bmjopen-2017-021418. PubMed 29909373 ↗
  • Siew ED, Parr SK, Wild MG, Levea SL, Mehta KG, Umeukeje EM, Silver SA, Ikizler TA, Cavanaugh KL. Kidney Disease Awareness and Knowledge among Survivors ofAcute Kidney Injury. Am J Nephrol. 2019;49(6):449-459. doi: 10.1159/000499862. Epub 2019 Apr 17. PubMed 30995659 ↗
  • Greer RC, Liu Y, Crews DC, Jaar BG, Rabb H, Boulware LE. Hospital discharge communications during care transitions for patients with acute kidney injury: a cross-sectional study. BMC Health Serv Res. 2016 Aug 30;16(1):449. doi: 10.1186/s12913-016-1697-7. PubMed 27577888 ↗
  • Hung AM, Siew ED, Wilson OD, Perkins AM, Greevy RA Jr, Horner J, Abdel-Kader K, Parr SK, Roumie CL, Griffin MR, Ikizler TA, Speroff T, Matheny ME. Risk of Hypoglycemia Following Hospital Discharge in Patients With Diabetes and Acute Kidney Injury. Diabetes Care. 2018 Mar;41(3):503-512. doi: 10.2337/dc17-1237. Epub 2018 Jan 11. PubMed 29326106 ↗
  • Silver SA, Harel Z, McArthur E, Nash DM, Acedillo R, Kitchlu A, Garg AX, Chertow GM, Bell CM, Wald R. 30-Day Readmissions After an Acute Kidney Injury Hospitalization. Am J Med. 2017 Feb;130(2):163-172.e4. doi: 10.1016/j.amjmed.2016.09.016. Epub 2016 Oct 14. PubMed 27751901 ↗
  • Siew ED, Parr SK, Abdel-Kader K, Eden SK, Peterson JF, Bansal N, Hung AM, Fly J, Speroff T, Ikizler TA, Matheny ME. Predictors of Recurrent AKI. J Am Soc Nephrol. 2016 Apr;27(4):1190-200. doi: 10.1681/ASN.2014121218. Epub 2015 Aug 11. PubMed 26264853 ↗
  • Siew ED, Abdel-Kader K, Perkins AM, Greevy RA Jr, Parr SK, Horner J, Vincz AJ, Denton J, Wilson OD, Hung AM, Robinson-Cohen C, Matheny ME. Timing of Recovery From Moderate to Severe AKI and the Risk for Future Loss of Kidney Function. Am J Kidney Dis. 2020 Feb;75(2):204-213. doi: 10.1053/j.ajkd.2019.05.031. Epub 2019 Sep 16. PubMed 31537394 ↗
  • Silver SA, Chertow GM. The Economic Consequences of Acute Kidney Injury. Nephron. 2017;137(4):297-301. doi: 10.1159/000475607. Epub 2017 Jun 9. PubMed 28595193 ↗
  • Ikizler TA, Parikh CR, Himmelfarb J, Chinchilli VM, Liu KD, Coca SG, Garg AX, Hsu CY, Siew ED, Wurfel MM, Ware LB, Faulkner GB, Tan TC, Kaufman JS, Kimmel PL, Go AS; ASSESS-AKI Study Investigators. A prospective cohort study of acute kidney injury and kidney outcomes, cardiovascular events, and death. Kidney Int. 2021 Feb;99(2):456-465. doi: 10.1016/j.kint.2020.06.032. Epub 2020 Jul 22. PubMed 32707221 ↗
  • Heung M, Steffick DE, Zivin K, Gillespie BW, Banerjee T, Hsu CY, Powe NR, Pavkov ME, Williams DE, Saran R, Shahinian VB; Centers for Disease Control and Prevention CKD Surveillance Team. Acute Kidney Injury Recovery Pattern and Subsequent Risk of CKD: An Analysis of Veterans Health Administration Data. Am J Kidney Dis. 2016 May;67(5):742-52. doi: 10.1053/j.ajkd.2015.10.019. Epub 2015 Dec 12. PubMed 26690912 ↗
  • Coca SG, Singanamala S, Parikh CR. Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int. 2012 Mar;81(5):442-8. doi: 10.1038/ki.2011.379. Epub 2011 Nov 23. PubMed 22113526 ↗
  • Zeng X, McMahon GM, Brunelli SM, Bates DW, Waikar SS. Incidence, outcomes, and comparisons across definitions of AKI in hospitalized individuals. Clin J Am Soc Nephrol. 2014 Jan;9(1):12-20. doi: 10.2215/CJN.02730313. Epub 2013 Oct 31. PubMed 24178971 ↗
  • Hoste EA, Bagshaw SM, Bellomo R, Cely CM, Colman R, Cruz DN, Edipidis K, Forni LG, Gomersall CD, Govil D, Honore PM, Joannes-Boyau O, Joannidis M, Korhonen AM, Lavrentieva A, Mehta RL, Palevsky P, Roessler E, Ronco C, Uchino S, Vazquez JA, Vidal Andrade E, Webb S, Kellum JA. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med. 2015 Aug;41(8):1411-23. doi: 10.1007/s00134-015-3934-7. Epub 2015 Jul 11. PubMed 26162677 ↗

Individual participant data

Plan to share: No — Individual participant data will not be shared at this time because this is a pilot feasibility study, and the dataset is expected to be small and potentially identifiable due to the clinical context, recruitment sites, hospitalization timing, and post-discharge care details. Aggregate study results may be shared through presentations and publications. The IPD sharing plan may be updated in the future if appropriate approvals, de-identification procedures, and data use agreements are established.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2026 (actual). Primary completion is estimated for Dec 2026, 6 months after the start.

Of 251 non-industry interventional studies with no phase under Acute Kidney Injury, half reached primary completion within 27 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 44. This study's planned 6 months is below that.

Counting every sponsor, half of 269 studies reached it within 26 months; a quarter within 12 and three quarters within 44.

How these figures are worked out, and which studies are left out of them.

Registered
May 29, 2026
First posted
Jun 4, 2026
StartActual
Jun 24, 2026
Primary completionEst.
Dec 31, 2026
CompletionEst.
Oct 30, 2027
Last update
Oct 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Oct 20, 2026
Sites
2 sites added — first site in United States
Show 2 added (2 United States)
  • Long Island Jewish Medical Center · Glen Oaks, United States
  • North Shore University Hospital · Manhasset, United States
Oct 20, 2026
Start date
Jun 1, 2026→Jun 24, 2026 (actual)
Oct 20, 2026
Secondary outcomes
1 added, 3 description edited
What changed in the outcomes
  • AddedSelf-management behaviors related to kidney healthTime frame: 4 weeks after hospital discharge
  • DescriptionAKI Knowledge Score: how it is measured was reworded
  • DescriptionPatient experience during care transitions: how it is measured was reworded
  • DescriptionSelf-management behaviors related to kidney health: how it is measured was reworded
Oct 20, 2026
Title
COordiNated CommuNication, Education, and Care Transitions After Acute Kidney Injury (CONNECT-AKI)- A Pilot Randomized Controlled Trial
Oct 20, 2026
Show all 1 update
  1. Oct 20, 2026
    Not yet recruiting→Recruiting
    2 sites added — first site in United States
    Show 2 added (2 United States)
    • Long Island Jewish Medical Center · Glen Oaks, United States
    • North Shore University Hospital · Manhasset, United States
    Start date Jun 1, 2026→Jun 24, 2026 (now actual)
    Secondary outcomes 1 added, 3 description edited
    What changed in the outcomes
    • AddedSelf-management behaviors related to kidney healthTime frame: 4 weeks after hospital discharge
    • DescriptionAKI Knowledge Score: how it is measured was reworded
    • DescriptionPatient experience during care transitions: how it is measured was reworded
    • DescriptionSelf-management behaviors related to kidney health: how it is measured was reworded
    Title COordiNated CommuNication, Education, and Care Transitions After Acute Kidney Injury (CONNECT-AKI)- A Pilot Randomized Controlled Trial
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07626268
Lead sponsor
Northwell Health
Responsible party
Sponsor
First posted
Jun 4, 2026
Start date
Jun 24, 2026
Primary completion
Dec 31, 2026 (estimated)
Completion
Oct 30, 2027 (estimated)
Last update
Oct 20, 2026

Study contacts

Jia Hwei Ng, MD, MSCE
Contact
jng10@northwell.edu
516-465-8200
Farwa Batool, MPH
Contact
fbatool@northwell.edu
Jia Hwei Ng, MD, MSCE
principal investigator · Northwell Health

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion